tirzepatide stocks Eli Lilly Stock Gains After Study Shows Weight-Loss Drug Combats Sleep Apnea Antidiabetic drug, tirzepatide molecul |

(This story has been updated to add a video.)

Rising demand for effective weight loss medications has fueled a sharp increase in health plan spending, placing employers under new financial pressure to manage costs while still offering meaningful weight loss benefits

The combination creates a 7-10 day window of heightened headache risk after each dose change

A helpful rule of thumb: If a product claims to be a cheap, easy, over-the-counter alternative to prescription GLP-1s, skepticism is warranted

GLP-1s just make that combination easy to fall into

Treatments are generally spaced about 4-5 weeks apart, which allows most people to easily accommodate multiple procedures into their schedules